Research map: U.S. student pharmacists perspectives on the pharmacogenomics of escitalopram and aripiprazole

Back to the article

Papers in this map

  1. The Serotonin Theory of Depression: A Systematic Umbrella Review of the Evidence · Joanna Moncrieff · 2022 · 933 citations · Cited by this paper
  2. How to implement pre-emptive pharmacogenetic testing in the acute hospital setting · 2025 · Related
  3. Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for CYP2D6 , CYP2C19 , CYP2B6 , SLC6A4 , and HTR2A Genotypes and Serotonin Reuptake Inhibitor Antidepressants · Chad Bousman · 2023 · 454 citations · Cited by this paper
  4. Opportunities and challenges for the implementation of pharmacogenomics in supportive care for gastrointestinal cancer patients in Zimbabwe · 2025 · Related
  5. Aripiprazole Augmentation in Major Depressive Disorder: A Double-Blind, Placebo-Controlled Study in Patients with Inadequate Response to Antidepressants · Robert Berman · 2009 · 260 citations · Cited by this paper
  6. ADIPOQ genotypes and haplotypes, circulating adiponectin levels and responsiveness to antihypertensive therapy in preeclampsia · 2025 · Related
  7. Effect of Pharmacogenomic Testing for Drug-Gene Interactions on Medication Selection and Remission of Symptoms in Major Depressive Disorder · David W. Oslin · 2022 · 205 citations · Cited by this paper
  8. UGT1A6 variants and deferiprone-induced ADRs: a complication-specific analysis in Iranian thalassemia patients · 2025 · Related
  9. Serum levels of aripiprazole and dehydroaripiprazole, clinical response and side effects · Katrin M. Kirschbaum · 2008 · 123 citations · Cited by this paper
  10. Pharmacogenomic testing for Prader-Willi syndrome: a mixed methods analysis of caregiver experiences and utilization · 2025 · Related
  11. Influence of CYP2C19 Metabolizer Status on Escitalopram/Citalopram Tolerability and Response in Youth With Anxiety and Depressive Disorders · Stacey L. Aldrich · 2019 · 121 citations · Cited by this paper
  12. Pharmacogenomics of anthracycline-cyclophosphamide-taxane chemotherapy: an influence of CYP polymorphisms and BMI on breast cancer treatment outcomes · 2025 · Related
  13. 5-HT Receptors and the Development of New Antidepressants · Grzegorz Ślifirski · 2021 · 110 citations · Cited by this paper
  14. Whole exome sequencing identifies rare variants involved in PPIX-metabolizing pathway in anti-TB drug-induced hepatitis · 2025 · Related
  15. The STAR*D Trial: It is Time to Reexamine the Clinical Beliefs That Guide the Treatment of Major Depression · H. Edmund Pigott · 2015 · 96 citations · Cited by this paper
  16. Antiplatelet therapy in high-bleeding risk patients with acute coronary syndrome: pharmacogenomics in the era of precision medicine · 2026 · Related
  17. Influence of CYP 2D6, CYP 3A4, CYP 3A5 and ABCB 1 Polymorphisms on Pharmacokinetics and Safety of Aripiprazole in Healthy Volunteers · Carmen Belmonte · 2018 · 90 citations · Cited by this paper
  18. Pharmacogenomics for stratified antidepressant treatment in major depressive disorder: evidence, limits and a roadmap for clinical use · 2026 · Related
  19. PharmGKB summary · Katrin Sangkuhl · 2011 · 85 citations · Cited by this paper
  20. Pharmacogenomics of current antiretroviral drugs · 2026 · Related
  21. Influence of CYP2D6 and CYP2C19 gene variants on antidepressant response in obsessive-compulsive disorder · Eva J. Brandl · 2013 · 71 citations · Cited by this paper
  22. Pharmacogenomic and pharmacogenetic-guided therapy as a tool in precision medicine: current state and factors impacting acceptance by stakeholders · Gregory P. Hess · 2015 · 58 citations · Cited by this paper
  23. The Role of Pharmacogenetics in Personalizing the Antidepressant and Anxiolytic Therapy · Milica Radosavljević · 2023 · 57 citations · Cited by this paper
  24. Cost-effectiveness of pharmacogenomic-guided treatment for major depression · Shahzad Ghanbarian · 2023 · 52 citations · Cited by this paper
  25. Mechanisms of SSRI Therapy and Discontinuation · Trevor Sharp · 2023 · 45 citations · Cited by this paper
  26. Opportunities for pharmacists to integrate pharmacogenomics into clinical practice · Yanting Wang · 2019 · 39 citations · Cited by this paper
  27. Reimbursement of pharmacogenetic tests at a tertiary academic medical center in the United States · Lauren K. Lemke · 2023 · 34 citations · Cited by this paper
  28. Escitalopram versus other antidepressive agents for major depressive disorder: a systematic review and meta-analysis · Juntao Yin · 2023 · 33 citations · Cited by this paper
  29. Aripiprazole and Dehydroaripiprazole Plasma Concentrations and Clinical Responses in Patients With Schizophrenia · Shih‐Ku Lin · 2011 · 31 citations · Cited by this paper
  30. The discovery, structure, and function of 5-HTR1E serotonin receptor · Vinay Sharma · 2023 · 17 citations · Cited by this paper
  31. Pharmacogenetics testing for poor response to antidepressants: a transnosographic case series · Marie-Agnès Lorvellec · 2024 · 14 citations · Cited by this paper
  32. Providers’ Use of Pharmacogenetic Testing to Inform Antidepressant Prescribing: Results of Qualitative Interviews · Bonnie M. Vest · 2023 · 10 citations · Cited by this paper
  33. Combined effect of CYP2C19 and CYP2D6 genotypes on escitalopram serum concentration and its metabolic ratio in a European patient population · Pari Faraj · 2024 · 7 citations · Cited by this paper
  34. Pharmacogenomics and antidepressants: efficacy and adverse drug reactions · Joseph F. Goldberg · 2022 · 2 citations · Cited by this paper

Source: OpenAlex (CC0)